edgepedia

Medical and health researchers

8,517 articles

Salvatore Siena

Salvatore Siena is an Italian medical oncologist who has directed the Oncologia Falck division at Milan's Niguarda Cancer Center since 1999, leading trials including HERACLES and DESTINY-CRC01 in colorectal cancer.

Salvatore V. Pizzo

Salvatore V. Pizzo is a pathologist at Duke University who chaired its Pathology department from 1991 to 2014 and identified ATP synthase as angiostatin's endothelial receptor.

Sam Gandy

Sam Gandy, or Samuel E. Gandy, is an American neurologist and Alzheimer's researcher who led the 1989 discovery of the first drugs that could lower amyloid formation in the brain.

Sam M. Janes

Sam M. Janes, also known as Sam Janes, is a British respiratory physician at University College London who leads SUMMIT, Europe's largest lung cancer screening trial.

Sam Schulman

Sam Schulman is a Swedish-trained physician-scientist in hematology and blood coagulation, a McMaster University professor since 2004 who directs the Thrombosis Service at Hamilton General Hospital and led landmark trials on oral anticoagulants.

Sam Shuster

Sam Shuster (born 1927) is a British dermatologist and emeritus professor at Newcastle University whose research links skin disease to the gut, hormones, and aging.

Samba Ousemane Sow

Samba Ousemane Sow is a Malian doctor and epidemiologist who directs the CVD-Mali vaccine research center in Bamako and served as Mali's health minister from 2017 to 2019.

Samba Ousmane Sow

Samba Ousmane Sow is a Malian epidemiologist who directs the vaccine research center CVD-Mali in Bamako and served as Mali's Minister of Health from 2017 to 2019.

Sami Viskin

Sami Viskin (Samuel Viskin) is an Israeli cardiologist and researcher on inherited arrhythmias at Tel Aviv Sourasky Medical Center, and editor in chief of the journal Heart Rhythm since 2024.

Samih H. Nasr

Samih Nasr is a renal pathologist at Mayo Clinic in Rochester, Minnesota, known for work on kidney disease caused by monoclonal immunoglobulins, including MGRS and PGNMID.

Samir Hanash

Samir Hanash is a cancer proteomics researcher and professor at MD Anderson Cancer Center in Houston, where he directs the McCombs Institute for early cancer detection.

Samir Jaber

Samir Jaber, born 1967, is a French anesthesiologist and intensivist, full professor since 2007 and head of Anesthesia and Critical Care at Saint-Eloi University Hospital, Montpellier.

Samir Kapadia

Samir Kapadia is an American interventional cardiologist who chairs cardiovascular medicine at Cleveland Clinic and led major trials of transcatheter aortic valve replacement, including PROTECTED TAVR.

Samra Turajlic

Samra Turajlic is a cancer researcher and medical oncologist who studies how tumors evolve and spread, and is known for leading the TRACERx Renal study of kidney cancer evolution.

Samuel A. Bozzette

Samuel A. Bozzette is an American infectious diseases physician and health services researcher, Emeritus Professor of Medicine at UC San Diego, known for national studies of HIV care in the United States.

Samuel A. Levine

Samuel A. Levine (1891–1966) was an American cardiologist and Harvard professor whose six-grade murmur scale, Levine sign, and early mobilization after heart attack remain part of medicine.

Samuel A. Wells

Samuel A. Wells is an American endocrine surgeon at the National Cancer Institute who pioneered prophylactic thyroidectomy for inherited RET mutations and led the ZETA trial of vandetanib.

Samuel Achilefu

Samuel Achilefu is a molecular imaging scientist and inaugural chair of Biomedical Engineering at UT Southwestern Medical Center, known for Cancer Vision Goggles for image-guided cancer surgery.

Samuel Alexander Kinnier Wilson

Samuel Alexander Kinnier Wilson (1874 or 1878 to 1937) was a British neurologist, born in New Jersey, whose 1912 description of progressive lenticular degeneration gave medicine Wilson's disease.

Samuel Aparicio

Samuel Aparicio is a molecular pathologist and breast cancer genomicist at BC Cancer and the University of British Columbia, co-leading the METABRIC breast cancer taxonomy study.

Samuel B. Guzé

Samuel B. Guze (1923–2000) was an American psychiatrist at Washington University in St. Louis who, with Eli Robins and George Winokur, built the medical model of reliable psychiatric diagnosis that shaped the Feighner criteria and DSM-III.

Samuel Bedson

Sir Samuel Phillips Bedson (1886–1969) was a British bacteriologist who showed during the 1929–1930 psittacosis pandemic that its cause was a filterable agent, later grouped as Chlamydia.

Samuel Benchimol

Samuel Benchimol is a Canadian cancer biologist known for research on the p53 tumor suppressor gene and for identifying the ligase Pirh2, which promotes p53 degradation.

Samuel Cohen (biophysical chemist)

Samuel I. A. Cohen is a Cambridge-trained biophysical chemist who established how toxic amyloid-β oligomers arise during aggregation in Alzheimer's disease, and who co-founded Wren Therapeutics and Ride Therapeutics.

Samuel D. Wright

Samuel D. Wright is an immunologist who worked at Rockefeller University and later Merck Research Laboratories, known for identifying the CR3 receptor and the LPS–CD14 endotoxin recognition pathway.

Samuel E. Lux

Samuel E. Lux IV is an American physician-scientist in pediatric hematology at Harvard Medical School, known for three decades of work on the red blood cell membrane skeleton and hereditary spherocytosis.

Samuel H. Boyer

Samuel H. Boyer (1924–2006) was an American physician-scientist at Johns Hopkins University whose biochemical genetics research on hemoglobin variation helped lay the basis for sickle cell disease drug therapy.

Samuel Hellman

Samuel Hellman is an American radiation oncologist, A. N. Pritzker Distinguished Service Professor Emeritus at the University of Chicago, who with Ralph Weichselbaum originated the oligometastases concept.

Samuel I. Rapaport

Samuel I. Rapaport (1921–2011) was an American hematologist who created the kaolin-activated partial thromboplastin time, the APTT clotting screening test, and later reported tissue factor pathway inhibitor from his UC San Diego laboratory in 1985.

Samuel James Meltzer

Samuel James Meltzer (1851–1920) was an American physiologist and pharmacologist who headed physiology and pharmacology at the Rockefeller Institute and pioneered artificial respiration by tracheal insufflation.